Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Briller med fokus på emmetropisering hos kinesiske barn

17. november 2026 oppdatert av: Children's Hospital of Fudan University

Effekt av perifere briller med fokus på emmetropisering hos kinesiske barn i alderen 6-8 år: 2 år randomisert klinisk forsøk.

The purpose of this study is to characterize the effects of peripheral focous-out glasses on emmetropization in non-myopic Chinese Children Aged 6-8 Years.This is a prospective, parallel-controlled randomized trial.

Studieoversikt

Detaljert beskrivelse

Myopia is one of the most common eye diseases that cause visual impairment and blindness, and the high rate of myopia in young people is a major public health issue. Based on the clinical studies of optical defocusing to regulate eye growth and refractive changes through visual signal feedback, we hypothesize that early wearing of peripheral defocus glasses in children can slow down the process of emmetropization and even prevent the onset of myopia by producing more myopic defocusing. The aim of this study is to investigate whether wearing peripheral defocus glasses can effectively delay emmetropization in non-myopic children aged 6-8 years , and to further explore its effect on preventing the onset of myopia.

The study adopts a 2-year,single-centre, randomized, parallel-controlled trial with a non-blinded design. Subjects who pass the screening period will have their baseline data collected and will be assigned to the experimental or control groups according to the randomization principle. The experimental group will be fitted with Direct Emmetropia with Focus-out Glasses (hereafter referred to as DEFOG) to guide the emmetropization process. The control group will be given no treatment and will be a blank control. Baseline data including visual acuity, cycloplegic objective refraction, axis length, accommodation amplitude, strabismus examination, pupil size, choroidal thickness and peripheral retinal refraction will be measured when enrolled in the group and follow-up data will be measured at month 6, 12, 18 and 24. The primary interest of this study will be studied by comparing the difference in cycloplegic objective refraction changes between month 24 and baseline in the two groups of subjects.

Studietype

Intervensjonell

Registrering (Faktiske)

160

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Kina, 201110
        • Children's Hospital of Fudan University

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

6 år til 8 år (Barn)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  1. Age: ≥6 and ≤8 years at enrollment.
  2. At least one parent' s Spherical equivalent refraction≤-3.00D.
  3. Spherical equivalent refractions (SERs) under cycloplegia: +0.50 to +1.50 diopters (D)
  4. Astigmatism ≤1.00 D .
  5. Anisometropia ≤1.00 D.
  6. Best Corrected Visual Acuity (BCVA) : 1.0 or better
  7. Provision of consent written by subject's legal guardian
  8. Willing and able to participate in all required activities of the study

Exclusion Criteria:

  1. Any of the following abnormalities on the ocular surface, such as trachoma, pemphigoid, chemical injury, heat burn, radiation injury, etc.
  2. Eyelid abnormalities (e.g. entropion, ectropion, tumor, edema, blepharospasm, incomplete eyelid closure, severe trichiasis, severe ptosis) ,which affect eyelid function in either eye
  3. Eye diseases such as strabismus, amblyopia, anisometropia, fundus diseases, and accommodation abnormality,etc.
  4. Prior treatment of myopia control in either eye, including but not limited to drugs, orthokeratology, low-level red-light therapy, etc.
  5. Noncompliance with measurement at enrollment.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: DEFOG group

Subjescts will wear DEFOG glasses(peripheral focus-out glasses).

Subjects in the intervention group will wear peripheral focus-out glasses ≧8 hours a day and ≧5 days a week.

Ingen inngripen: Control group

Subjects in the control group will just be observed.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Overall Changes of Cycloplegic Objective Refraction(spherical equivalent refraction, SER)(D)
Tidsramme: From baseline till the 24th month

Changes of cycloplegic objective refraction(i.e reflected by SER) from baseline till the 24th month (only the right-eye data included). Objective refraction data will be examined by AUTO REF/KERATOMETER. Ciliary muscle paralysis will be performed by using 1% cyclopentanone eye drops, 2 doses in each eye, 2 doses 5 minutes apart. The optometry will be performed after 20 minutes of complete ciliary muscle paralysis (disappearance of pupil response to light or pupil diameter at least greater than 6 mm). SER is calculated by adding the sum of the sphere power with half of the cylinder power. Baseline data will be measured at the time of enrollment. Follow-up data will be measured on the 24th month from baseline. The 24th month data will be subtracted from the baseline data to obtain changes.

From baseline till the 24th month

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Changes of Cycloplegic Objective Refraction(SER) (D)
Tidsramme: The 6th month, the 12th month and the 18th month from baseline

Changes of cycloplegic objective refraction (i.e reflected by SER) different follow-up time and the baseline time (only the right-eye data included). Objective refraction data will be examined by AUTO REF/KERATOMETER.

The 6th month, the 12th month and the 18th month from baseline
Myopia
Tidsramme: The 6th month, the 12th month, the 18th month and the 24th month from baseline

Cycloplegic SER≦-0.50D at any follow-up time. Objective refraction data will be examined by AUTO REF/KERATOMETER.

The 6th month, the 12th month, the 18th month and the 24th month from baseline
Changes of Axial Length(AL)(mm)
Tidsramme: The 6th month, the 12th month, the 18th month and the 24th month from baseline

Changes of Axial Length (AL) between different follow-up time and the baseline time (only the right-eye data included).AL will be examined by IOL Master.

The 6th month, the 12th month, the 18th month and the 24th month from baseline
Amplitude of Accommodation (AMP)(D)
Tidsramme: The 6th month, the 12th month, the 18th month and the 24th month from baseline

Amplitude of Accommodation (AMP) at any follow-up time (only the right-eye data included). AMP will be examined by lens test.

The 6th month, the 12th month, the 18th month and the 24th month from baseline
Uncorrected Visual Acuity
Tidsramme: The 6th month, the 12th month, the 18th month and the 24th month from baseline

The Logarithmic Visual Acuity at any follow-up time (only the right-eye data included).

The 6th month, the 12th month, the 18th month and the 24th month from baseline
Strabismus Examination(△)
Tidsramme: The 6th month, the 12th month, the 18th month and the 24th month from baseline

Strabismus examination at any follow-up time by SYNOPTOPHORE.

The 6th month, the 12th month, the 18th month and the 24th month from baseline
Changes of Choroidal Thickness (ChT) (um)
Tidsramme: The 6th month, the 12th month, the 18th month and the 24th month from baseline

Changes of Choroidal Thickness (ChT)between different follow-up time and the baseline time (only the right-eye data included). ChT will be examined by OPTICALCOHERENCETOMOGRAPHY.

The 6th month, the 12th month, the 18th month and the 24th month from baseline
Pupil size(mm)
Tidsramme: The 6th month, the 12th month, the 18th month and the 24th month from baseline

Pupil size at any follow-up time (only the right-eye data included).

The 6th month, the 12th month, the 18th month and the 24th month from baseline
Peripheral Retinal Refraction(D)
Tidsramme: The 6th month, the 12th month, the 18th month and the 24th month from baseline

Peripheral Retinal Refraction at any follow-up time (only the right-eye data included). Peripheral Retinal Refraction will be examined by AUTO FUNDUS CAMERA.

The 6th month, the 12th month, the 18th month and the 24th month from baseline
The percentage of participants with fast myopic shift
Tidsramme: From baseline till the 24th month

The percentage of participants with fast myopic shift over 2 years(only the right-eye data included). The fast myopic shift is defined as cycloplegic objective refraction (i.e reflected by SER) myopic shift of at least 1.00 D. Objective refraction data will be examined by AUTO REF/KERATOMETER.

From baseline till the 24th month
Corneal curvature(D) or radius of curvature(mm)
Tidsramme: The 6th month, the 12th month, the 18th month and the 24th month from baseline

Corneal curvature or radius of curvature(only the right-eye included). They can be interconverted. Data will be examined by AUTO REF/KERATOMETER.

The 6th month, the 12th month, the 18th month and the 24th month from baseline
Astigmatism (D)
Tidsramme: The 6th month, the 12th month, the 18th month and the 24th month from baseline

The adtigmatism at any follow-up time (only the right-eye data included).

The 6th month, the 12th month, the 18th month and the 24th month from baseline

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

23. mars 2023

Primær fullføring (Faktiske)

2. april 2026

Studiet fullført (Faktiske)

2. april 2026

Datoer for studieregistrering

Først innsendt

10. januar 2023

Først innsendt som oppfylte QC-kriteriene

10. januar 2023

Først lagt ut (Faktiske)

19. januar 2023

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

20. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

17. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • DEFOG

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere